These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 29857135

  • 1. Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro.
    Meola TR, Dening TJ, Prestidge CA.
    Eur J Pharm Biopharm; 2018 Aug; 129():145-153. PubMed ID: 29857135
    [Abstract] [Full Text] [Related]

  • 2. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
    Dening TJ, Rao S, Thomas N, Prestidge CA.
    Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
    Yasmin R, Tan A, Bremmell KE, Prestidge CA.
    J Pharm Sci; 2014 Sep; 103(9):2950-2959. PubMed ID: 24585389
    [Abstract] [Full Text] [Related]

  • 5. Enhancing the oral bioavailability of simvastatin with silica-lipid hybrid particles: The effect of supersaturation and silica geometry.
    Meola TR, Schultz HB, Peressin KF, Prestidge CA.
    Eur J Pharm Sci; 2020 Jul 01; 150():105357. PubMed ID: 32446169
    [Abstract] [Full Text] [Related]

  • 6. Porous Silica-Supported Solid Lipid Particles for Enhanced Solubilization of Poorly Soluble Drugs.
    Yasmin R, Rao S, Bremmell KE, Prestidge CA.
    AAPS J; 2016 Jul 01; 18(4):876-85. PubMed ID: 27048207
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Supersaturated silica-lipid hybrids (super-SLH): An improved solid-state lipid-based oral drug delivery system with enhanced drug loading.
    Schultz HB, Thomas N, Rao S, Prestidge CA.
    Eur J Pharm Biopharm; 2018 Apr 01; 125():13-20. PubMed ID: 29277724
    [Abstract] [Full Text] [Related]

  • 9. Impact of solidification on the performance of lipid-based colloidal carriers: oil-based versus self-emulsifying systems.
    Alinaghi A, Tan A, Rao S, Prestidge CA.
    Curr Drug Deliv; 2015 Apr 01; 12(1):16-25. PubMed ID: 25030115
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.
    Tan A, Davey AK, Prestidge CA.
    Pharm Res; 2011 Sep 01; 28(9):2273-87. PubMed ID: 21560021
    [Abstract] [Full Text] [Related]

  • 13. The Influence of Solidification on the in vitro Solubilisation of Blonanserin Loaded Supersaturated Lipid-Based Oral Formulations.
    Møller A, Schultz HB, Meola TR, Müllertz A, Prestidge CA.
    Eur J Pharm Sci; 2021 Feb 01; 157():105640. PubMed ID: 33189902
    [Abstract] [Full Text] [Related]

  • 14. Tableting lipid-based formulations for oral drug delivery: a case study with silica nanoparticle-lipid-mannitol hybrid microparticles.
    Bremmell KE, Tan A, Martin A, Prestidge CA.
    J Pharm Sci; 2013 Feb 01; 102(2):684-93. PubMed ID: 23242712
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.